Guardant Health
GH
#3559
Rank
A$4.62 B
Marketcap
$37.63
Share price
-1.18%
Change (1 day)
-11.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -A$0.74 B

According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -A$0.74 B. In 2023 the company made an earning of -A$0.72 B an increase over its 2022 earnings that were of -A$0.99 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.74 B2.7%
2023 -A$0.72 B-26.73%
2022 -A$0.99 B69.96%
2021 -A$0.58 B56.35%
2020 -A$0.37 B252.69%
2019 -A$0.11 B-17.22%
2018 -A$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.44 B-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$21.46 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA